Annotation Detail for RABGGTA

Basic Information
Top
Pathway ID | Pathway Name |
---|
200006 | Signaling events mediated by PRL |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of RABGGTA mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of RABGGTA mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of RABGGTA mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of RABGGTA mRNA | affects expression | 16483693
|
D001241 |
Aspirin |
Aspirin results in increased expression of RABGGTA mRNA | increases expression | 11906190
|
D014812 |
Vitamin K |
Vitamin K affects the expression of RABGGTA mRNA | affects expression | 16844298
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
4.41 | 7525203 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.02 | 18287403 |
MESH:D055963 |
Asthma, Aspirin-Induced |
|
Aspirin |
4.97 | 12372130 20485159 |
MESH:D001932 |
Brain Neoplasms |
|
Aspirin |
4.72 | 15481559 |
MESH:D001943 |
Breast Neoplasms |
|
Aspirin |
3.19 | 15161893 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
5.09 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
5.09 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Vitamin K |
5.09 | 16328049 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.79 | 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.98 | 6135515 |
MESH:D003110 |
Colonic Neoplasms |
|
Aspirin |
3.02 | 12411196 |
MESH:D015179 |
Colorectal Neoplasms |
|
Aspirin |
2.75 | 17047198 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.45 | 15095906 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
12.32 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
12.32 | 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.77 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.77 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
6.77 | 21346803 |
MESH:D004487 |
Edema |
|
Aspirin |
4.21 | 17259670 |
MESH:D005909 |
Glioblastoma |
|
Aspirin |
4.14 | 12870263 |
MESH:D006261 |
Headache |
|
Aspirin |
5.48 | 15240983 |
MESH:D012001 |
Hyperacusis |
|
Aspirin |
6.28 | 15240983 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
8.27 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.27 | 16705839 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.24 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.72 | 2876784 6135515 2876786 |
MESH:D008881 |
Migraine Disorders |
|
Aspirin |
4.28 | 15240983 |
MESH:D009203 |
Myocardial Infarction |
|
Aspirin |
3.66 | 12692751 |
MESH:D009325 |
Nausea |
|
Aspirin |
5.73 | 15240983 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.94 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.94 | 7678174 18551238 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
16.99 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
16.99 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
16.99 | 14694615 |
MESH:D010003 |
Osteoarthritis |
|
Aspirin |
4.23 | 7009135 |
MESH:D010146 |
Pain |
|
Aspirin |
4.11 | 6995502 6363464 |
MESH:D010438 |
Peptic Ulcer Hemorrhage |
|
Aspirin |
6.00 | 11156591 |
MESH:D020795 |
Photophobia |
|
Aspirin |
6.28 | 15240983 |
MESH:D012220 |
Rhinitis |
|
Aspirin |
4.68 | 12372130 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.56 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.56 | 18551238 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Aspirin |
5.68 | 12269725 |
MESH:D020521 |
Stroke |
|
Aspirin |
4.63 | 16403987 |
MESH:D013927 |
Thrombosis |
|
Aspirin |
4.80 | 17672075 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.36 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.36 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
13.58 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
13.58 | 10091137 |
MESH:D014581 |
Urticaria |
|
Aspirin |
4.79 | 20485159 10982225 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB04464 |
- |
N-Formylmethionine |
|
DB07752 |
- |
FARNESYL |
|
DB07780 |
- |
FARNESYL DIPHOSPHATE |
|
DB07841 |
- |
GERANYLGERANYL DIPHOSPHATE |
|